FGF19 and hepatocellular carcinoma: Fibroblast growth factor 19 (FGF19) is a driver oncogene that is amplified in approximately 14% of HCC patients and overexpressed in 50% of HCC patients, making the FGF19 gene a novel potential target for the treatment of HCC [340, 341].